Department of Cardiology, Peking University Hospital, Beijing, China.
Circ Arrhythm Electrophysiol. 2011 Apr;4(2):143-8. doi: 10.1161/CIRCEP.110.958405. Epub 2011 Feb 8.
The efficacy of additional complex fractionated atrial electrogram (CFAE) ablation after pulmonary vein antrum isolation (PVAI) in patients with atrial fibrillation (AF) remains controversial. This meta-analysis was performed to assess the additional efficacy of CFAEs ablation after a single procedure without antiarrhythmic drugs.
Trials were identified in MEDLINE, Cochrane Library, Embase, Google Scholar, reviews, and reference lists of relevant papers. Controlled cohort studies comparing the long-term efficacy of combined CFAEs plus PVAI ablation with PVAI alone were included. The primary end point was the maintenance of sinus rhythm without antiarrhythmic drugs. Seven controlled trials (9 comparisons) with a total of 622 participants (332 patients underwent PVAI plus CFAE ablation and 330 patients underwent PVAI alone) were included in the meta-analysis. In an overall pooled estimate, compared with PVI alone, long-term rates of sinus rhythm maintenance (relative risk, 1.17, 95% confidence interval, 1.03 to 1.33, P=0.019) were increased by additional CFAE ablation. Subgroup analysis demonstrated that additional CFAEs ablation increased rates of sinus rhythm maintenance in nonparoxysmal AF (relative risk, 1.35; 95% confidence interval, 1.04 to 1.75; P=0.022), whereas had no effect on patients with paroxysmal AF (relative risk, 1.04; 95% confidence interval, 0.92 to 1.18; P=0.528).
Adjuvant CFAE ablation in addition to standard PVAI increases the rate of long-term sinus rhythm maintenance in nonparoxysmal AF patients after a single procedure without antiarrhythmic drugs but does not provide additional benefit to sinus rhythm maintenance in paroxysmal AF patients.
在心房颤动(AF)患者中,在肺静脉隔离(PVAI)后进行额外的复杂碎裂心房电图(CFAE)消融的疗效仍存在争议。本荟萃分析旨在评估单次无抗心律失常药物治疗后进行 CFAE 消融的额外疗效。
在 MEDLINE、Cochrane 图书馆、Embase、Google Scholar、综述和相关论文的参考文献列表中检索试验。纳入比较 CFAE 加 PVAI 消融联合与单独 PVAI 消融长期疗效的对照队列研究。主要终点是无抗心律失常药物维持窦性心律。纳入了 7 项对照试验(9 项比较),共 622 名参与者(332 名患者接受 PVAI 加 CFAE 消融,330 名患者接受 PVAI 单独治疗)。总体汇总估计,与单独 PVI 相比,附加 CFAE 消融可提高窦性心律维持的长期比率(相对风险,1.17;95%置信区间,1.03 至 1.33;P=0.019)。亚组分析表明,附加 CFAE 消融可提高非阵发性 AF 患者的窦性心律维持率(相对风险,1.35;95%置信区间,1.04 至 1.75;P=0.022),而对阵发性 AF 患者则无影响(相对风险,1.04;95%置信区间,0.92 至 1.18;P=0.528)。
在标准 PVAI 基础上附加 CFAE 消融可提高单次无抗心律失常药物治疗后非阵发性 AF 患者长期窦性心律维持率,但对阵发性 AF 患者的窦性心律维持无额外益处。